Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

German stem cell licence for Parkinson's research:

This article was originally published in Clinica

Executive Summary

Germany's Robert Koch Institute for infectious diseases has issued its fifth licence for the importing of stems cells for research purposes to the Max Planck Institute for biophysical chemistry in Gottingen. The project for which the licence has been granted concerns the differentiation of human embryonic stem cells in dopamine neurons. The institute hopes the project will lead to a better understanding of the physiological processes of the brain as well as its failures, which are linked to Parkinson's disease.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT065130

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel